Our Blog Melanoma360

Featured image for “Regeneron Reports Fianlimab plus Libtayo Showed Above 60% Response Rate in Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors”
09/12/2022

Regeneron Reports Fianlimab plus Libtayo Showed Above 60% Response Rate in Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors

(NEWS PROVIDED BY Regeneron Pharmaceuticals, Inc. Sep 12, 2022, 02:30 ET) Positive clinical data presented in a mini-oral session at ESMO…
Blog - Melanoma360
Breaking News
Featured image for “Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma”
09/11/2022

Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma

Neoadjuvant IO Boosts High-Risk Melanoma EFS Results from the phase 2 SWOG S1801 study show that for patients given pembrolizumab…
Blog - Melanoma360
Breaking News
Featured image for “Survivor Spotlight: Erich & Jenn Djordjevic”
09/06/2022

Survivor Spotlight: Erich & Jenn Djordjevic

By Mara Klecker Note: Erich passed away on September 28th, 2022, the same week his story ran in our newsletter.…
Blog - Melanoma360
Friends, Family, & Caregivers
Featured image for “Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor”
09/06/2022

Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor

By Mara Klecker Bev Johnson figured the abnormal bleeding she was experiencing was a side effect of her IUD losing…
Blog - Melanoma360
Survivor Stories
Featured image for “The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author”
08/09/2022

The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author

When going through difficulty, many people turn to friends and family for support. But what happens when those people dismiss…
Blog - Melanoma360
Podcast
Featured image for “Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag”
07/22/2022

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag

(reprint from Business Wire, published: July 22, 2022) Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody…
Blog - Melanoma360
Breaking News
Featured image for “2022: The State of Sunscreen in the U.S.”
07/13/2022

2022: The State of Sunscreen in the U.S.

July is UV Safety Awareness Month, and with so much time spent outdoors, practicing sun safety should be top of…
Blog - Melanoma360
Featured image for “Sun Safety and Psychological Challenges For Melanoma Survivors”
07/13/2022

Sun Safety and Psychological Challenges For Melanoma Survivors

Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping…
Blog - Melanoma360
Podcast
Featured image for “Parenting While Living With Melanoma”
07/12/2022

Parenting While Living With Melanoma

by Mara Klecker It’s natural and common to worry about how a parent’s cancer diagnosis and treatment is going to…
Blog - Melanoma360
Friends, Family, & Caregivers
Survivor Stories
Featured image for “Survivorship: Living Well with Melanoma”
06/22/2022

Survivorship: Living Well with Melanoma

Cancer Survivorship begins the moment you learn of your diagnosis and continues long after treatment. And thanks to medical advances,…
Blog - Melanoma360
Podcast
09/12/2022

Regeneron Reports Fianlimab plus Libtayo Showed Above 60% Response Rate in Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors

(NEWS PROVIDED BY Regeneron Pharmaceuticals, Inc. Sep 12, 2022, 02:30 ET) Positive clinical data presented in a mini-oral session at ESMO…
Featured image for “Regeneron Reports Fianlimab plus Libtayo Showed Above 60% Response Rate in Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors”
Blog - Melanoma360
 | 
Breaking News
09/11/2022

Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma

Neoadjuvant IO Boosts High-Risk Melanoma EFS Results from the phase 2 SWOG S1801 study show that for patients given pembrolizumab…
Featured image for “Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma”
Blog - Melanoma360
 | 
Breaking News
09/06/2022

Survivor Spotlight: Erich & Jenn Djordjevic

By Mara Klecker Note: Erich passed away on September 28th, 2022, the same week his story ran in our newsletter.…
Featured image for “Survivor Spotlight: Erich & Jenn Djordjevic”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
09/06/2022

Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor

By Mara Klecker Bev Johnson figured the abnormal bleeding she was experiencing was a side effect of her IUD losing…
Featured image for “Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor”
Blog - Melanoma360
 | 
Survivor Stories
08/09/2022

The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author

When going through difficulty, many people turn to friends and family for support. But what happens when those people dismiss…
Featured image for “The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author”
Blog - Melanoma360
 | 
Podcast
07/22/2022

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag

(reprint from Business Wire, published: July 22, 2022) Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody…
Featured image for “Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag”
Blog - Melanoma360
 | 
Breaking News
07/13/2022

2022: The State of Sunscreen in the U.S.

July is UV Safety Awareness Month, and with so much time spent outdoors, practicing sun safety should be top of…
Featured image for “2022: The State of Sunscreen in the U.S.”
Blog - Melanoma360
07/13/2022

Sun Safety and Psychological Challenges For Melanoma Survivors

Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping…
Featured image for “Sun Safety and Psychological Challenges For Melanoma Survivors”
Blog - Melanoma360
 | 
Podcast
07/12/2022

Parenting While Living With Melanoma

by Mara Klecker It’s natural and common to worry about how a parent’s cancer diagnosis and treatment is going to…
Featured image for “Parenting While Living With Melanoma”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Survivor Stories
06/22/2022

Survivorship: Living Well with Melanoma

Cancer Survivorship begins the moment you learn of your diagnosis and continues long after treatment. And thanks to medical advances,…
Featured image for “Survivorship: Living Well with Melanoma”
Blog - Melanoma360
 | 
Podcast